1[1]Reaven GM. Role of insulin resistance in human disease.Diabetes. 1988; 37: 1595-1607
2[2]Scott M. H.Bryan Brewer. James I. etal. Definition of Metabolic Syndrome. Circulation. 2004; 109:433-438
3[3]Scott M. Barbara Hansen, Sidney C. etal. Clinical Management of Metabolic Syndrome. Circulation. 2004; 109:551-556
4[4]Chinali M. Devereux RB. Howard BV. etal. Comparison of Cardiac structure and function in American Indians with (the Strong Heart study). Am J Cardiol. 2004; 43:40-44
5[5]Van Bilsen M. Smeets PJ. Gilde AJ. etal.Metabolic remodelling of the failing heart:the Cardiac burn-out syndrome?Cardiovasc Res. 2004; 61:218-226
6[7]Abbasi F. Brown BW. Lamendola C. et al. Relationship between obesity, insulin resistance and coronary heart disease risk. J Am Coll Cardiol. 2002; 40:937-943
7[9]Juhan-Vage I. Haemostatic parameters and vascular risk.Atherosclerosis. 1996; 124(Suppl) :S49-S55
8[10]Rizzo MR. Ragno E. Barbieri M. etal. Elevated plasma activator inhibitor-1 is not related to insulin resistance and to gene polymorphism in healthy centanarians.Atherosclerosis. 2002; 160: 385-390
9[11]Sartori MT. Vettor R. de Pergola G. et al. Role of the 4G/5G poly- morphism of PAI-1 gene promoter on PAI-1levels in obese patients: influence of fat distribution and insulin resistance. Thromb Haemost. 2001; 86:1161-1169
10[12]Valle M, Gascon F, Martos R, et al. Relationship between high plasma leptin concentrations and metaboic syndrome in obese prepubertal children Int J obes Relat Metab Disord. 2003, 27(1): 13-18.
